Company intelligence / Profile preview

Lady Technologies

San Francisco, California, United Stateskegg.tech ↗

Ownership: Private
Development stage: Commercial

Overview

Lady Technologies has commercialized the kegg device—a unique FDA registered fertility tracker and pelvic floor trainer that uses impedance sensing to analyze cervical mucus. The company claims over 50,000–60,000 users/couples have used the product for conception support. Clinical results are not published in peer-reviewed journals but user testimonials report successful pregnancies. The company holds patents on its technology and continues R&D into broader women’s intimate/vaginal health applications beyond fertility.

Therapeutic areas: Women's Health
Modalities: DeviceNon-pharmacological therapy
Industry: Physiological Monitoring

Partnerships

No major pharma or biotech partnerships disclosed; investors include Relentless Consumer Partners, SOSV/HAX accelerator

Beyond the preview

Go deeper on Lady Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lady Technologies.

Explore the full profile